Market Research Logo

Biosurgery: Technologies and Global Markets

Biosurgery: Technologies and Global Markets

The global biosurgery market should reach $12.5 billion by 2021 from $8.3 billion in 2016 at a compound annual growth rate (CAGR) of 8.5%, from 2016 to 2021.

Report Includes
An overview of the global market for biosurgery.
Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
Segmentation of the market on the basis of product type, source, application, and region.
In depth coverage of the market dynamics, technology trends, drivers, constraints, and key strategies.
Discussion of government regulations, medical associations & international regulatory agencies.
Analysis of patents pertaining to biosurgery.
Profiles of companies related to the industry.


Report Scope

This report analyzes the market for products used to reduce excessive hemorrhage during surgery. In a surgical procedure, these products are used as adhesion agents to seal wounds and to repair damaged or weakened tissue. This report does not consider the revenue associated with the main surgery cost; rather, it considers the revenue spent on stoppage/minimization of damage to the adjacent tissue to minimize intraoperative and postoperative complications. Due to their ease of application, these products improve the work efficiency of surgeons. Biosurgery products can be used to disinfect wounds with the help of maggots, and are used particularly for chronic infected wounds, which do not get treated by antibiotics. This report covers all of the existing applications of biosurgery products.

The global biosurgery market is segmented primarily by product type, application, source, and region. Biosurgery products are segmented by type into anti-adhesive agents, hemostatic agents, surgical sealing agents, bone-graft substitutes, and soft-tissue management. The application segments include cardiothoracic surgery, neurosurgery and spine surgery, orthopedic surgery, and general surgery. Based on source, the biosurgery market is segmented into biological and synthetic products.

An in-depth analysis of these segments is given in this report. The report also provides a detailed qualitative account of the market dynamics, technology trends, key strategies, and regulatory scenario.

The market is segmented by region into North America, Europe, Asia-Pacific, and ROW, including further division into key countries. Companies profiled in this report include Johnson & Johnson (Ethicon) Baxter International Inc., Zimmer Biomet Holdings Inc., Wright Medical Group NV, C.R. Bard Inc., Medtronic Plc, Tissuemed Ltd., CryoLife Inc., Hemostasis LLC, Cohera Medical Inc., Kuros Biosciences, B. Braun Melsungen AG, Sanofi SA, Stryker Corp., Exactech Inc., Z-Medica Corp., RTI Surgical, Smith & Nephew Plc, and HyperBranch Medical Technology Inc.

CHAPTER 1 INTRODUCTION
STUDY OBJECTIVES
SCOPE OF REPORT
INTENDED AUDIENCE
SOURCE OF INFORMATION AND METHODOLOGY
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 EXECUTIVE SUMMARY
SUMMARY TABLE GLOBAL BIOSURGERY MARKET, BY REGION, THROUGH 2021 ($ MILLIONS)
SUMMARY FIGURE GLOBAL BIOSURGERY MARKET, BY REGION, 2015-2021 ($ MILLIONS)
CHAPTER 3 MARKET OVERVIEW
MARKET EVOLUTION AND INNOVATION
MERITS OF BIOSURGERY PROCEDURES
FIGURE 1 DIFFERENT TYPES OF BIOSURGERY THERAPIES
BONE-GRAFT SUBSTITUTE THERAPY
BIOLOGICAL HEMOSTATS THERAPY
BIOLOGICAL SEALANTS AND ANTI-ADHESIVE THERAPY
FIGURE 2 TIMELINE OF FIBRIN SEALANTS
BIOMESH THERAPY
MAGGOT THERAPY
GOVERNMENT REGULATIONS, MEDICAL ASSOCIATIONS, AND INTERNATIONAL
REGULATORY AGENCIES
RULES AND REGULATIONS SCENARIO IN THE U.S.
TABLE 1 MEDICAL DEVICE CLASSIFICATION
Pre-Market Approval (PMA)
PMA Supplements
TABLE 2 TYPES OF PMA SUPPLEMENTS
510(k) Notification
Traditional 510(k)
RULES AND REGULATIONS SCENARIO IN THE EUROPEAN UNION
TABLE 3 MEDICAL DEVICES BY CLASS
RULES AND REGULATIONS SCENARIO IN CHINA
RULES AND REGULATIONS SCENARIO IN JAPAN
TABLE 4 RULES AND REGULATIONS SCENARIO IN JAPAN
DEMOGRAPHICS, INCIDENCE AND PREVALENCE RATES, AND OTHER FACTORS
INFLUENCING BIOSURGERY MARKET GROWTH
AGING POPULATION
INCREASING PREVALENCE OF CHRONIC DISORDERS GLOBALLY
FIGURE 3 ESTIMATED PERCENT OF DEATHS CAUSED BY CHRONIC DISORDERS, 2020 (%)
FIGURE 4 NUMBER OF DEATHS CAUSED BY SEVERE CHRONIC DISORDER OR TRAUMA, 2012 (MILLIONS)
INCREASING HEALTHCARE EXPENDITURE
FIGURE 5 TOP COUNTRIES FOR HEALTH EXPENDITURES PER CAPITA ($)
CLINICAL GUIDELINES AND REIMBURSEMENT SCENARIO
U.S. HEALTHCARE STRUCTURAL CHARACTERISTICS
The Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (H.R. 1130, S. 598)
Medicare
Other Issues
TECHNOLOGY TRENDS
3-D TISSUE ASSEMBLY
BIO-THYROID
Expected Advantages of a Bio-Thyroid
PATENTS IN BIOMATERIALS
TABLE 5 MIMEDX: PATENT PORTFOLIO
BIOSURGERY PIPELINE
FIGURE 6 PIPELINE OF BIOSURGICAL PRODUCTS
NOVEL TECHNOLOGIES FOR THE FUTURE OF BIOSURGERY
3-D BIO-PRINTING
Direct Organ Manufacturing
BIO-PRINTING TISSUES AND ORGANS
MEDICAL ADVANTAGES OF 3-D PRINTING IN BIOSURGERY
Customization and Personalization
Bio-Printing Tissues and Organs
Customized Implants and Prostheses
BIO-PRINTERS
KEY STRATEGIES
FIGURE 7 KEY STRATEGIES IN BIOSURGERY MARKET (%)
MARKET DYNAMICS
DRIVERS
Increase in the Incidence of Chronic Diseases
Increasing Geriatric Population
FIGURE 8 GLOBAL LIFE EXPECTANCY OF GERIATRIC POPULATION, 2010-2050
Increase in the Obese and Overweight Population
Advantages of Biosurgery over Traditional Surgical Methods
RESTRAINTS
High Costs
Lack of Awareness and Societal Disapproval
Popularity of Minimally Invasive Surgeries
OPPORTUNITIES
Improvement in Healthcare Infrastructure
Presence of Multifunctional Products
CHAPTER 4 BIOSURGERY MARKET BY PRODUCT TYPE
FIGURE 9 DIFFERENT TYPES OF NATURAL BIOSURGICAL SEALANTS
TABLE 6 GLOBAL BIOSURGERY MARKET BY PRODUCT, THROUGH 2021 ($ MILLIONS)
ANTI-ADHESIVE AGENTS
ANTI-ADHESIVE AGENTS BY APPLICATION
Pharmacological Agents
Barrier Agents
Hydro-Floatation Agents
Solid-Barrier Anti-Adhesive Agents
TABLE 7 GLOBAL MARKET FOR ANTI-ADHESIVE AGENTS BY REGION, THROUGH 2021 ($ MILLIONS)
HEMOSTATIC AGENTS
TYPES OF HEMOSTATIC AGENTS
Mechanical Hemostatic Agents
Thermal Based-Energy Hemostatic Agents
Chemical Hemostatic Agents
Topical Hemostatic Agents
Passive Hemostatic Agents
Active Hemostatic Agents
Flowable Products
TABLE 8 GLOBAL MARKET FOR HEMOSTATIC AGENTS BY REGION, THROUGH 2021 ($ MILLIONS)
SURGICAL SEALING AGENTS
TABLE 9 GLOBAL MARKET FOR SURGICAL SEALING AGENTS BY TYPE, THROUGH 2021 ($ MILLIONS)
TABLE 10 GLOBAL MARKET FOR SURGICAL SEALING AGENTS BY REGION, THROUGH 2021 ($ MILLIONS)
SURGICAL SEALING AGENTS AVAILABLE IN THE MARKET
TABLE 11 KEY SURGICAL SEALING AGENTS AVAILABLE IN THE MARKET
NATURAL SURGICAL SEALING AGENTS
TABLE 12 GLOBAL MARKET FOR NATURAL SURGICAL SEALING AGENTS BY REGION, THROUGH 2021 ($ MILLIONS)
Fibrin Sealants or Glues
Gelatin-Based Sealants
Human Fibrinogen and Thrombin Fleece
Oxidized Regenerated Methylcellulose
Albumin-Based Sealants
Glutaraldehyde-Based Adhesive
SYNTHETIC SURGICAL SEALING AGENTS
TABLE 13 GLOBAL MARKET FOR SYNTHETIC SURGICAL SEALING AGENTS BY REGION, THROUGH 2021 ($ MILLIONS)
Polyethylene Glycol (PEG) Sealant
Cyanoacrylates
BONE-GRAFT SUBSTITUTES
TABLE 14 GLOBAL MARKET FOR BONE-GRAFT SUBSTITUTES BY REGION, THROUGH 2021 ($ MILLIONS)
TABLE 15 DIFFERENT TYPES OF BONE-GRAFT SUBSTITUTES
TYPES OF BONE-GRAFT SUBSTITUTES
TABLE 16 KEY OSTEOBIOLOGIC PRODUCTS AVAILABLE IN THE MARKET
TABLE 17 GLOBAL MARKET FOR BONE-GRAFT SUBSTITUTES BY TYPE, THROUGH 2021 ($ MILLIONS)
CELL-BASED MATRICES
Trinity Multipotential Cellular Bone Matrix
TABLE 18 GLOBAL MARKET FOR CELL-BASED MATRICES BY REGION, THROUGH 2021 ($ MILLIONS)
BONE MORPHOGENETIC PROTEINS
BMP-2
BMP-7
TABLE 19 GLOBAL MARKET FOR BONE MORPHOGENETIC PROTEINS BY REGION, THROUGH 2021 ($ MILLIONS)
DEMINERALIZED BONE MATRIX
FIGURE 10 STEPS INVOLVED IN DOWNSTREAM PROCESSING OF DEMINERALIZED BONE MATRIX (DBM)
TABLE 20 GLOBAL MARKET FOR DEMINERALIZED BONE MATRIX BY REGION, THROUGH 2021 ($ MILLIONS)
SYNTHETIC GRAFT EXTENDER
TABLE 21 COMMON MATERIALS USED TO MANUFACTURE SYNTHETICS
TABLE 22 GLOBAL MARKET FOR SYNTHETIC GRAFT EXTENDERS BY REGION, THROUGH 2021 ($ MILLIONS)
SOFT-TISSUE MANAGEMENT/MESH/PATCH
TABLE 23 GLOBAL MARKET FOR SOFT-TISSUE PATCH/MESH BY TYPE, THROUGH 2021 ($ MILLIONS)
TABLE 24 GLOBAL MARKET FOR SOFT-TISSUE PATCH/MESH BY REGION, THROUGH 2021 ($ MILLIONS)
TYPES OF SOFT TISSUE-MANAGEMENT MESH/PATCH
TABLE 25 KEY SOFT TISSUE-MANAGEMENT PRODUCTS AVAILABLE IN THE MARKET
TABLE 26 KEY SURGICAL MESHES AVAILABLE IN THE MARKET
Natural Mesh/Patch
TABLE 27 GLOBAL MARKET FOR NATURAL MESH/PATCH BY REGION, THROUGH 2021 ($ MILLIONS)
TABLE 28 TYPES OF NATURAL MESHES
Synthetic Mesh/Patch
TABLE 29 GLOBAL MARKET FOR SYNTHETIC MESH/PATCH BY REGION, THROUGH 2021 ($ MILLIONS)
TABLE 30 TYPES OF SYNTHETIC MESHES
CHAPTER 5 BIOSURGERY MARKET BY APPLICATION
TABLE 31 GLOBAL MARKET FOR BIOSURGERY BY APPLICATION, THROUGH 2021 ($ MILLIONS)
CARDIOTHORACIC SURGERY
TABLE 32 GLOBAL BIOSURGERY MARKET FOR CARDIO AND THORACIC SURGERY APPLICATION BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 11 BONE GRAFTS: PROCESS FLOWCHART
TABLE 33 TYPES OF CARDIOVASCULAR DISEASES
CARDIOVASCULAR DISEASE RISK FACTORS
COMMON SYMPTOMS OF CARDIOVASCULAR DISEASES
SYMPTOMS OF RHEUMATIC HEART DISEASE
NEUROSURGERY AND SPINE SURGERY
TABLE 34 GLOBAL BIOSURGERY MARKET FOR NEURO AND SPINE SURGERY APPLICATION BY REGION, THROUGH 2021 ($ MILLIONS)
ORTHOPEDIC SURGERY
TABLE 35 GLOBAL BIOSURGERY MARKET FOR ORTHOPEDIC SURGERY APPLICATION BY REGION, THROUGH 2021 ($ MILLIONS)
REVISION HIP ARTHROPLASTY
PEDIATRICS
TRAUMA SURGERY
SPORTS MEDICINE
TABLE 36 STAGES OF GRAFT HEALING AND THEIR CHARACTERISTICS
GENERAL SURGERY
TABLE 37 GLOBAL BIOSURGERY MARKET FOR GENERAL SURGERY APPLICATION BY REGION, THROUGH 2021 ($ MILLIONS)
INCIDENCE RATES OF SURGICAL PROCEDURES AND ANALYSIS
CHAPTER 6 BIOSURGERY MARKET BY SOURCE
TABLE 38 GLOBAL MARKET FOR BIOSURGERY PRODUCTS BY SOURCE TYPE, THROUGH 2021 ($ MILLIONS)
NATURAL/BIOLOGICAL PRODUCTS
TABLE 39 GLOBAL BIOSURGERY MARKET FOR NATURAL PRODUCT SOURCES BY REGION, THROUGH 2021 ($ MILLIONS)
FIBRIN-BASED PRODUCTS
ALBUMIN-BASED PRODUCTS
THROMBIN-BASED PRODUCTS
COLLAGEN-BASED PRODUCTS
GELATIN-BASED PRODUCTS
SYNTHETIC PRODUCTS
TABLE 40 GLOBAL BIOSURGERY MARKET FOR SYNTHETIC PRODUCT
SOURCES BY REGION, THROUGH 2021 ($ MILLIONS)
POLYETHYLENE GLYCOL POLYMER-BASED PRODUCTS
CYANOACRYLATE-BASED PRODUCTS
BIODEGRADABLE MATERIALS
NONBIODEGRADABLE MATERIAL
CHAPTER 7 COMPETITIVE LANDSCAPE
TABLE 41 KEY COMPETITIVE STRATEGIES, 2014-2016 (NUMBER/%)
FIGURE 12 KEY COMPETITIVE STRATEGIES, 2014-2016 (%)
PRODUCT DEVELOPMENT
TABLE 42 PRODUCT DEVELOPMENT STRATEGY BY COMPANY, 2014-2016 (NUMBER/%)
FIGURE 13 PRODUCT DEVELOPMENT STRATEGY BY COMPANY, 2014-2016 (%)
TABLE 43 LIST OF KEY PRODUCT DEVELOPMENTS ANNOUNCED, 2014-2016
AGREEMENT
TABLE 44 AGREEMENT STRATEGY BY COMPANY, 2014-2016 (NUMBER/%)
FIGURE 14 AGREEMENT STRATEGY BY COMPANY, 2014-2016 (%)
TABLE 45 LIST OF KEY AGREEMENTS ANNOUNCED, 2014-2016
ACQUISITION
TABLE 46 ACQUISITIONS OR MERGERS BY COMPANY, 2014-2016 (NUMBER/%)
FIGURE 15 ACQUISITION STRATEGY BY COMPANY, 2014-2016 (%)
TABLE 47 LIST OF KEY ACQUISITIONS ANNOUNCED, 2014-2016
EXPANSION
TABLE 48 EXPANSIONS BY COMPANY, 2014-2016 (NUMBER/%)
FIGURE 16 EXPANSION STRATEGY BY COMPANY, 2014-2016 (%)
TABLE 49 LIST OF KEY EXPANSIONS, 2014-2016
CHAPTER 8 BIOSURGERY MARKET BY REGION
TABLE 50 GLOBAL BIOSURGERY MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 17 GLOBAL MARKET FOR BIOSURGERY BY REGION, 2015 (%)
FIGURE 18 TOP COUNTRIES FOR AESTHETIC SURGICAL PROCEDURES, 2014 (%)
FIGURE 19 PATENTS GRANTED BY DIFFERENT ORGANIZATIONS IN BIOSURGERY RESEARCH, 2015 (%)
FIGURE 20 TOP COMPANIES RECEIVING PATENTS FOR BIOMATERIALS IN 2015 (%)
NORTH AMERICA
TABLE 51 NORTH AMERICAN BIOSURGERY MARKET BY PRODUCT, THROUGH 2021 ($ MILLIONS)
FIGURE 21 NORTH AMERICAN SHARE OF BIOSURGERY MARKET BY COUNTRY, 2015 (%)
TABLE 52 NORTH AMERICAN BIOSURGERY MARKET BY COUNTRY, THROUGH 2021 ($ MILLIONS)
FIGURE 22 NORTH AMERICA R &D INVESTMENT, 2014 (%)
U.S.
FIGURE 23 DIABETES PREVALENCE AMONG DIFFERENT AMERICAN ETHNICITIES (%)
CANADA
FIGURE 24 CANADA MEDICAL DEVICE MARKET, 2012 (%)
TABLE 53 TOP 10 CANADIAN MEDICAL DEVICE EXPORTS, 2012 ($/%)
MEXICO
EUROPE
TABLE 54 EUROPEAN BIOSURGERY MARKET BY PRODUCT, THROUGH 2021 ($ MILLIONS)
TABLE 55 EUROPEAN BIOSURGERY MARKET BY COUNTRY, THROUGH 2021 ($ MILLIONS)
FIGURE 25 EUROPEAN BIOSURGERY MARKET BY COUNTRY, 2015 (%)
FIGURE 26 BREAKDOWN OF CHRONIC DISORDERS IN EUROPE, 2015 (%)
EUROPEAN UNION INVESTMENT SCENARIO
FIGURE 27 ESTIMATED EUROPEAN UNION EXPENDITURE ON RESEARCH, DEVELOPMENT AND INNOVATION, 2014-2020 (%)
EU HEALTH PROGRAM 2014-2020
INNOVATIVE MEDICINES INITIATIVE PROGRAM
U.K.
FIGURE 28 FLOW OF FUNDS BETWEEN THE U.K. AND EUROPEAN UNION, 2007-2013 (%)
GERMANY
FIGURE 29 DEATHS PER 100,000 FROM HEART DISEASE IN 2013 (NUMBER)
FRANCE
REST OF EUROPE
ASIA-PACIFIC
TABLE 56 ASIA-PACIFIC BIOSURGERY MARKET BY PRODUCT, THROUGH 2021 ($ MILLIONS)
TABLE 57 ASIA-PACIFIC BIOSURGERY MARKET BY COUNTRY, THROUGH 2021 ($ MILLIONS)
FIGURE 30 ASIA-PACIFIC BIOSURGERY MARKET BY COUNTRY, 2015 (%)
CHINA
FIGURE 31 BREAKDOWN OF CHRONIC DISORDERS IN CHINA (2014) (%)
INDIA
FIGURE 32 TOTAL NUMBER OF DEATHS IN INDIA FROM CHRONIC DISORDERS, 2015-2020 (MILLIONS)
FIGURE 33 PERCENTAGE OF CARDIOVASCULAR PATIENTS BY AREA IN INDIA, 2013 (%)
JAPAN
FIGURE 34 STRATIFICATION OF GERIATRIC POPULATION STATISTICS, BY AGE IN JAPAN (%)
AUSTRALIA
REST OF ASIA
REST OF WORLD
TABLE 58 REST OF WORLD BIOSURGERY MARKET BY PRODUCT, THROUGH 2021 ($ MILLIONS)
FIGURE 35 REST OF WORLD BIOSURGERY MARKET BY COUNTRY, 2015 (%)
TABLE 59 REST OF WORLD BIOSURGERY MARKET BY COUNTRY, THROUGH 2021 ($ MILLIONS)
LATIN AMERICA
CHAPTER 9 PATENT ANALYSIS
FIGURE 36 PATENTS REGISTERED/APPROVED WORLDWIDE, 2010-2016 (%)
U.S. PATENT ANALYSIS
BY PRODUCT TYPE
FIGURE 37 U.S. PATENT ANALYSIS BY PRODUCT, 2010-2016 (%)
BY MARKET PARTICIPANTS
FIGURE 38 U.S. PATENT ANALYSIS BY MARKET PARTICIPANT, 2010-2016
(%)
EUROPE PATENT ANALYSIS
BY PRODUCT TYPE
FIGURE 39 EUROPE PATENT ANALYSIS BY PRODUCT, 2010-2016 (%)
BY MARKET PARTICIPANTS
FIGURE 40 EUROPE PATENT ANALYSIS BY MARKET PARTICIPANT, 2010-2016 (%)
JAPAN PATENT ANALYSIS
BY PRODUCT TYPE
FIGURE 41 JAPAN PATENT ANALYSIS BY PRODUCT, 2010-2016 (%)
BY MARKET PARTICIPANTS
FIGURE 42 JAPAN PATENT ANALYSIS BY MARKET PARTICIPANT, 2010-2016 (%)
CHINA PATENT ANALYSIS
BY PRODUCT TYPE
FIGURE 43 CHINA PATENT ANALYSIS BY PRODUCT, 2010-2016 (%)
BY MARKET PARTICIPANTS
FIGURE 44 CHINA PATENT ANALYSIS BY MARKET PARTICIPANT, 2010-2016 (%)
KOREA PATENT ANALYSIS
BY PRODUCT TYPE
FIGURE 45 KOREA PATENT ANALYSIS BY PRODUCT, 2010-2016 (%)
BY MARKET PARTICIPANTS
FIGURE 46 KOREA PATENT ANALYSIS BY MARKET PARTICIPANT, 2010-2016 (%)
CHAPTER 10 COMPANY PROFILES
B. BRAUN MELSUNGEN AG
BIOSURGERY PRODUCT PORTFOLIO
TABLE 60 B. BRAUN: RECENT DEVELOPMENTS, 2014-2016
TABLE 61 B. BRAUN: FINANCIALS, 2013-2015 ($ MILLIONS/%)
BAXTER INTERNATIONAL INC.
BIOSURGERY PRODUCT PORTFOLIO
TABLE 62 BAXTER: RECENT DEVELOPMENTS, 2014-2016
TABLE 63 BAXTER: FINANCIALS, 2013-2015 ($ MILLIONS/%)
CERAPEDICS INC.
BIOSURGERY PRODUCT PORTFOLIO
TABLE 64 CERAPEDICS INC.: RECENT DEVELOPMENTS, 2014-2016
COHERA MEDICAL INC.
BIOSURGERY PRODUCT PORTFOLIO
TABLE 65 COHERA: RECENT DEVELOPMENTS, 2014-2016
C.R. BARD INC.
BIOSURGERY PRODUCT PORTFOLIO
TABLE 66 C.R. BARD: RECENT DEVELOPMENTS, 2014-2016
TABLE 67 C.R. BARD: FINANCIALS, 2013-2015 ($ MILLIONS/%)
CRYOLIFE INC.
BIOSURGERY PRODUCT PORTFOLIO
TABLE 68 CRYOLIFE: RECENT DEVELOPMENTS, 2014-2016
TABLE 69 CRYOLIFE: FINANCIALS, 2013-2015 ($ MILLIONS/%)
EXACTECH INC.
BIOSURGERY PRODUCT PORTFOLIO
TABLE 70 EXATECH INC.: RECENT DEVELOPMENTS, 2014-2016
TABLE 71 EXATECH INC. FINANCIALS, 2013-2015 ($ MILLIONS/%)
HEMOSTASIS LLC
BIOSURGERY PRODUCT PORTFOLIO
HYPERBRANCH MEDICAL TECHNOLOGY INC.
BIOSURGERY PRODUCT PORTFOLIO
TABLE 72 HYPERBRANCH MEDICAL TECHNOLOGY: RECENT
DEVELOPMENTS, 2014-2016
JOHNSON & JOHNSON
BIOSURGERY PRODUCT PORTFOLIO
TABLE 73 JOHNSON & JOHNSON: RECENT DEVELOPMENTS, 2014-2016
TABLE 74 JOHNSON & JOHNSON: FINANCIALS, 2013-2015 ($ MILLIONS/%)
KUROS BIOSCIENCES AG
BIOSURGERY PRODUCT PORTFOLIO
TABLE 75 KUROS BIOSCIENCES: RECENT DEVELOPMENTS, 2014-2016
TABLE 76 KUROS BIOSCIENCES: FINANCIALS, 2013-2015 ($ MILLIONS/%)
MEDTRONIC PLC
BIOSURGERY PRODUCT PORTFOLIO
TABLE 77 MEDTRONIC: RECENT DEVELOPMENTS, 2014-2016
TABLE 78 MEDTRONIC: FINANCIALS, 2014-2016 ($ MILLIONS/%)
RTI SURGICAL
BIOSURGERY PRODUCT PORTFOLIO
TABLE 79 RTI SURGICAL: RECENT DEVELOPMENTS, 2014-2016
TABLE 80 RTI SURGICAL: FINANCIALS, 2013-2015 ($ MILLIONS/%)
SANOFI SA
BIOSURGERY PRODUCT PORTFOLIO
TABLE 81 SANOFI SA: RECENT DEVELOPMENTS, 2014-2016
TABLE 82 SANOFI SA: FINANCIALS, 2013-2015 ($ MILLIONS/%)
SMITH & NEPHEW PLC
BIOSURGERY PRODUCT PORTFOLIO
TABLE 83 SMITH & NEPHEW: RECENT DEVELOPMENTS, 2014-2016
TABLE 84 SMITH & NEPHEW: FINANCIALS, 2013-2015 ($ MILLIONS/%)
STRYKER CORP.
BIOSURGERY PRODUCT PORTFOLIO
TABLE 85 STRYKER CORP.: RECENT DEVELOPMENTS, 2011-2016
TABLE 86 STRYKER CORP.: FINANCIALS, 2013-2015 ($ MILLIONS/%)
TISSUEMED LTD.
BIOSURGERY PRODUCT PORTFOLIO
TABLE 87 TISSUEMED: RECENT DEVELOPMENTS, 2014-2016
TABLE 88 TISSUEMED: FINANCIALS, 2013-2015 ($ MILLIONS/%)
WRIGHT MEDICAL GROUP NV
BIOSURGERY PRODUCT PORTFOLIO
TABLE 89 WRIGHT: RECENT DEVELOPMENTS, 2014-2016
TABLE 90 WRIGHT: FINANCIALS, 2013-2015 ($ MILLIONS/%)
Z-MEDICA CORP.
BIOSURGERY PRODUCT PORTFOLIO
TABLE 91 Z-MEDICA: RECENT DEVELOPMENTS, 2014-2016
ZIMMER BIOMET HOLDINGS INC.
BIOSURGERY PRODUCT PORTFOLIO
TABLE 92 ZIMMER BIOMET HOLDINGS INC.: RECENT DEVELOPMENTS, 2014-2016
TABLE 93 ZIMMER BIOMET HOLDINGS INC.: FINANCIALS, 2013-2015 ($ MILLIONS/%)
CHAPTER 11 APPENDIX
TABLE 94 LIST OF PATENTS: U.S.
TABLE 95 LIST OF PATENTS: CHINA
TABLE 96 LIST OF PATENTS: JAPAN
TABLE 97 LIST OF PATENTS: EUROPE
TABLE 98 LIST OF PATENTS: KOREA

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report